Home / Recalls / Apollo Care / D-0580-2018

D-0580-2018 Class II Terminated

Recalled by Apollo Care — Columbia, MO

Recall Details

Product Type
Drugs
Report Date
March 14, 2018
Initiation Date
February 15, 2018
Termination Date
May 31, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
312 bags

Product Description

Vancomycin 1.25g added to 250mL of 0.9% Sodium Chloride IV bag, Rx only, APOLLOcare, 3801 Mojave Ct., Suite 101, Columbia, MO 65202, NDC 71170-264-25.

Reason for Recall

Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.

Distribution Pattern

Medical Facility in MO

Code Information

Lot: AC-015560, Exp 03/14/2018

Other recalls by Apollo Care

  • D-0409-2025 Class II — FentaNYL 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (0.1%) added to 250 mL, 0.9% (April 15, 2025)
  • D-0634-2023 Class II — FentaNYL 50 mcg/mL (2,500mcg Total Dose), 50 mL Syringe, Rx Only, Apollo Care, L (May 2, 2023)
  • D-0632-2023 Class II — PHENYLephrine HCl Injection, 1 mg per 10 mL (100 mcg/mL), Single-Use Syringe, So (May 2, 2023)
  • D-0643-2023 Class II — VANComycin 2.5 g added to 500 mL of 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)
  • D-0633-2023 Class II — Succinylcholine Cl Injection, 100 mg per 5 mL (20 mg/mL), Single-Use Syringe, Rx (May 2, 2023)
  • D-0645-2023 Class II — VANComycin 750mg added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)
  • D-0635-2023 Class II — Ketamine Injection, 50 mg per 5 mL (10 mg/mL), Single-Use Syringe, Rx only, Apol (May 2, 2023)
  • D-0640-2023 Class II — VANComycin 1 g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apoll (May 2, 2023)
  • D-0637-2023 Class II — Norepinephrine 8 mg added to 250 mL 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)
  • D-0638-2023 Class II — VANComycin 1.25g added to 250 mL of 0.9% Sodium Chloride Injection, Rx Only, Apo (May 2, 2023)